Covetrus, Inc is a health information services business based in the US. Covetrus shares (CVET) are listed on the NASDAQ and all prices are listed in US Dollars. Covetrus employs 5,275 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Covetrus
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CVET – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Covetrus stock price (NASDAQ: CVET)Use our graph to track the performance of CVET stocks over time.
Covetrus shares at a glance
|Latest market close||$27.74|
|52-week range||$18.74 - $40.78|
|50-day moving average||$26.36|
|200-day moving average||$30.28|
|Wall St. target price||$33.83|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.30|
Buy Covetrus shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Covetrus stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Covetrus price performance over time
|1 week (2021-07-20)||N/A|
|1 month (2021-07-01)||2.63%|
|3 months (2021-04-30)||-3.18%|
|6 months (2021-01-27)||N/A|
|1 year (2020-07-27)||N/A|
|2 years (2019-07-27)||N/A|
|3 years (2018-07-27)||N/A|
|5 years (2016-07-27)||N/A|
Is Covetrus under- or over-valued?
Valuing Covetrus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Covetrus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Covetrus's PEG ratio
Covetrus's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3174. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Covetrus's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Covetrus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $132 million.
The EBITDA is a measure of a Covetrus's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.4 billion|
|Gross profit TTM||$798 million|
|Return on assets TTM||-0.67%|
|Return on equity TTM||0%|
|Market capitalisation||$3.5 billion|
TTM: trailing 12 months
Shorting Covetrus shares
There are currently 4.5 million Covetrus shares held short by investors – that's known as Covetrus's "short interest". This figure is 3% up from 4.4 million last month.
There are a few different ways that this level of interest in shorting Covetrus shares can be evaluated.
Covetrus's "short interest ratio" (SIR)
Covetrus's "short interest ratio" (SIR) is the quantity of Covetrus shares currently shorted divided by the average quantity of Covetrus shares traded daily (recently around 641892.98998569). Covetrus's SIR currently stands at 6.99. In other words for every 100,000 Covetrus shares traded daily on the market, roughly 6990 shares are currently held short.
However Covetrus's short interest can also be evaluated against the total number of Covetrus shares, or, against the total number of tradable Covetrus shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Covetrus's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Covetrus shares in existence, roughly 30 shares are currently held short) or 0.0453% of the tradable shares (for every 100,000 tradable Covetrus shares, roughly 45 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Covetrus.
Find out more about how you can short Covetrus stock.
Covetrus share dividends
We're not expecting Covetrus to pay a dividend over the next 12 months.
Covetrus share price volatility
Over the last 12 months, Covetrus's shares have ranged in value from as little as $18.74 up to $40.775. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Covetrus's is 2.0477. This would suggest that Covetrus's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Covetrus, Inc. , together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific.
Stocks similar to Covetrus
Covetrus in the news
Were Hedge Funds Right About Covetrus, Inc. (CVET)?
Covetrus Announces Second Quarter 2021 Earnings Release Date and Conference Call Information
Covetrus Announces Second Quarter 2021 Earnings Release Date and Conference Call Information
Frequently asked questionsWhat percentage of Covetrus is owned by insiders or institutions?
Currently 0.355% of Covetrus shares are held by insiders and 97.505% by institutions. How many people work for Covetrus?
Latest data suggests 5,275 work at Covetrus. When does the fiscal year end for Covetrus?
Covetrus's fiscal year ends in December. Where is Covetrus based?
Covetrus's address is: 7 Custom House Street, Portland, ME, United States, 04101 What is Covetrus's ISIN number?
Covetrus's international securities identification number is: US22304C1009 What is Covetrus's CUSIP number?
Covetrus's Committee on Uniform Securities Identification Procedures number is: 22304C100
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert